APO Research
Talk to an analyst

APO RESEARCH · REPORT

Hemostatic Gel

Hemostatic gel is used as an adjunct or alternative to standard suture techniques to control bleeding or wound closure.In recent years, global hemostatic gels have developed rapidly, with an average growth rate of around 7%.In 2018, global production of hemostatic gels was about 3.26 million pieces.In 2018, China accounted for about 3 percent of global sales.In the next five years, China's hemostatic gel products will continue to grow rapidly.Hemostatic gels are mainly divided into fibrin, gelatin and others, among which fibrin accounts for the largest proportion, accounting for nearly 38% of the total market in 2018, while gelatin accounts for 28%.Hemostatic gels are mainly used in minimally invasive surgery, general surgery and other aspects, among which minimally invasive surgery is the main application field, accounting for 51% in 2018 and general surgery for 28%.Hemostatic gels are mainly divided into fibrin, gelatin and others, among which fibrin accounts for the largest proportion, accounting for nearly 38% of the total market in 2018, while gelatin accounts for 28%.Hemostatic gels are mainly used in minimally invasive surgery, general surgery and other aspects, among which minimally invasive surgery is the main application field, accounting for 51% in 2018 and general surgery for 28%.Baxter, J&J, CryoLife, Integra Life Sciences are major suppliers.These suppliers have mastered key technologies and patents, and have a fixed customer base, which has formed a monopoly situation in the market.The growth of the elderly population and the increasing prevalence of chronic diseases are the driving factors affecting the industry.More than 45 percent of americans have at least one chronic condition that requires intensive care, according to the CDC.Elderly patients require intensive care, are prone to injury and take a long time to heal.Chronic diseases eventually led to surgery, which in turn spurred the development of the hemostatic gel industry.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Hemostatic gel is used as an adjunct or alternative to standard suture techniques to control bleeding or wound closure.In recent years, global hemostatic gels have developed rapidly, with an average growth rate of around 7%.In 2018, global production of hemostatic gels was about 3.26 million pieces.In 2018, China accounted for about 3 percent of global sales.In the next five years, China's hemostatic gel products will continue to grow rapidly.Hemostatic gels are mainly divided into fibrin, gelatin and others, among which fibrin accounts for the largest proportion, accounting for nearly 38% of the total market in 2018, while gelatin accounts for 28%.Hemostatic gels are mainly used in minimally invasive surgery, general surgery and other aspects, among which minimally invasive surgery is the main application field, accounting for 51% in 2018 and general surgery for 28%.Hemostatic gels are mainly divided into fibrin, gelatin and others, among which fibrin accounts for the largest proportion, accounting for nearly 38% of the total market in 2018, while gelatin accounts for 28%.Hemostatic gels are mainly used in minimally invasive surgery, general surgery and other aspects, among which minimally invasive surgery is the main application field, accounting for 51% in 2018 and general surgery for 28%.Baxter, J&J, CryoLife, Integra Life Sciences are major suppliers.These suppliers have mastered key technologies and patents, and have a fixed customer base, which has formed a monopoly situation in the market.The growth of the elderly population and the increasing prevalence of chronic diseases are the driving factors affecting the industry.More than 45 percent of americans have at least one chronic condition that requires intensive care, according to the CDC.Elderly patients require intensive care, are prone to injury and take a long time to heal.Chronic diseases eventually led to surgery, which in turn spurred the development of the hemostatic gel industry.

Selected research

Industry Growth & Trends

Global Hemostatic Gel Industry Growth and Trends Forecast to 2032

27 December 202590 pages

Choose your research edition.

Industry ResearchHemostatic Gel Industry Research Report 2026121 pages · $2,950 USDIndustry Growth & TrendsGlobal Hemostatic Gel Industry Growth and Trends Forecast to 203290 pages · $3,450 USDMarket StructureGlobal Hemostatic Gel Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032184 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Hemostatic Gel Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal Hemostatic Gel Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

Hemostatic gel is used as an adjunct or alternative to standard suture techniques to control bleeding or wound closure.In recent years, global hemostatic gels have developed rapidly, with an average growth rate of around 7%.In 2018, global production of hemostatic gels was about 3.26 million pieces.In 2018, China accounted for about 3 percent of global sales.In the next five years, China's hemostatic gel products will continue to grow rapidly.Hemostatic gels are mainly divided into fibrin, gelatin and others, among which fibrin accounts for the largest proportion, accounting for nearly 38% of the total market in 2018, while gelatin accounts for 28%.Hemostatic gels are mainly used in minimally invasive surgery, general surgery and other aspects, among which minimally invasive surgery is the main application field, accounting for 51% in 2018 and general surgery for 28%.Hemostatic gels are mainly divided into fibrin, gelatin and others, among which fibrin accounts for the largest proportion, accounting for nearly 38% of the total market in 2018, while gelatin accounts for 28%.Hemostatic gels are mainly used in minimally invasive surgery, general surgery and other aspects, among which minimally invasive surgery is the main application field, accounting for 51% in 2018 and general surgery for 28%.Baxter, J&J, CryoLife, Integra Life Sciences are major suppliers.These suppliers have mastered key technologies and patents, and have a fixed customer base, which has formed a monopoly situation in the market.The growth of the elderly population and the increasing prevalence of chronic diseases are the driving factors affecting the industry.More than 45 percent of americans have at least one chronic condition that requires intensive care, according to the CDC.Elderly patients require intensive care, are prone to injury and take a long time to heal.Chronic diseases eventually led to surgery, which in turn spurred the development of the hemostatic gel industry.

Global Hemostatic Gel key players include Baxter, J&J, Advance Medical Solution, etc. Global top three manufacturers hold a share over 45%.

North America is the largest market, with a share over 60%, followed by Europe, with a share over 20 percent.

Read the full market overview

In terms of product, Fibrin is the largest segment, with a share over 35%. And in terms of application, the largest application is Minimally Invasive Surgery, followed by General Surgery, etc.

Report Scope

This report provides a structured, data-driven view of the global Hemostatic Gel market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Hemostatic Gel market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Hemostatic Gel market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Hemostatic Gel.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Hemostatic Gel market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Hemostatic Gel Market by Company

Baxter

J&J

CryoLife

Integra Life Sciences

Advance Medical Solution

BD

CSL Behring

Pfizer

B Braun

Hemostatic Gel Segment by Type

Fibrin

Gelatin

Other

Hemostatic Gel Segment by Application

Minimally Invasive Surgery

General Surgery

Others

Hemostatic Gel Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Hemostatic Gel market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Hemostatic Gel and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Hemostatic Gel.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Hemostatic Gel manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Hemostatic Gel in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Fibrin Table 2. Major Company of Gelatin Table 3. Major Company of Other Table 4. Global Hemostatic Gel Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Hemostatic Gel Sales by Type (2021-2026) & (K Units) Table 6. Global Hemostatic Gel Sales Market Share in Volume by Type (2021-2026) Table 7. Global Hemostatic Gel Sales by Type (2021-2026) & (US$ Million) Table 8. Global Hemostatic Gel Sales Market Share in Value by Type (2021-2026) Table 9. Global Hemostatic Gel Price by Type (2021-2026) & (US$/Unit) Table 10. Global Hemostatic Gel Sales by Type (2027-2032) & (K Units) Table 11. Global Hemostatic Gel Sales Market Share in Volume by Type (2027-2032) Table 12. Global Hemostatic Gel Sales by Type (2027-2032) & (US$ Million) Table 13. Global Hemostatic Gel Sales Market Share in Value by Type (2027-2032) Table 14. Global Hemostatic Gel Price by Type (2027-2032) & (US$/Unit) Table 15. North America Hemostatic Gel Sales by Type (2021-2026) & (K Units) Table 16. North America Hemostatic Gel Sales by Type (2021-2026) & (US$ Million) Table 17. Europe Hemostatic Gel Sales by Type (2021-2026) & (K Units) Table 18. Europe Hemostatic Gel Sales by Type (2021-2026) & (US$ Million) Table 19. Asia-Pacific Hemostatic Gel Sales by Type (2021-2026) & (K Units) Table 20. Asia-Pacific Hemostatic Gel Sales by Type (2021-2026) & (US$ Million) Table 21. Latin America Hemostatic Gel Sales by Type (2021-2026) & (K Units) Table 22. Latin America Hemostatic Gel Sales by Type (2021-2026) & (US$ Million) Table 23. Middle East and Africa Hemostatic Gel Sales by Type (2021-2026) & (K Units) Table 24. Middle East and Africa Hemostatic Gel Sales by Type (2021-2026) & (US$ Million) Table 25. Hemostatic Gel Industry Trends Table 26. Hemostatic Gel Industry Drivers Table 27. Hemostatic Gel Industry Opportunities and Challenges Table 28. Hemostatic Gel Industry Restraints Table 29. Global Hemostatic Gel Sales Revenue by Company (US$ Million) & (2021-2026) Table 30. Global Hemostatic Gel Revenue Market Share by Company (2021-2026) Table 31. Global Hemostatic Gel Sales by Company (2021-2026) & (K Units) Table 32. Global Hemostatic Gel Sales Share by Company (2021-2026) Table 33. Global Hemostatic Gel Market Price by Company (2021-2026) & (US$/Unit) Table 34. Global Hemostatic Gel Industry Company Ranking, 2024 VS 2025 VS 2026 Table 35. Global Hemostatic Gel Major Company Production Sites and Headquarters Table 36. Global Hemostatic Gel Company, Product Type & Application Table 37. Global Hemostatic Gel Company Establishment Date Table 38. Global Company Market Concentration Ratio (CR5 and HHI) Table 39. Global Hemostatic Gel by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 40. Global Hemostatic Gel Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 41. Global Hemostatic Gel Sales by Region (2021-2026) & (K Units) Table 42. Global Hemostatic Gel Sales Market Share in Volume by Region (2021-2026) Table 43. Global Hemostatic Gel Sales by Region (2021-2026) & (US$ Million) Table 44. Global Hemostatic Gel Sales Market Share in Value by Region (2021-2026) Table 45. Global Hemostatic Gel Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 46. Global Hemostatic Gel Sales by Region (2027-2032) & (K Units) Table 47. Global Hemostatic Gel Sales Market Share in Volume by Region (2027-2032) Table 48. Global Hemostatic Gel Sales by Region (2027-2032) & (US$ Million) Table 49. Global Hemostatic Gel Sales Market Share in Value by Region (2027-2032) Table 50. Global Hemostatic Gel Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 51. Global Hemostatic Gel Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 52. Global Hemostatic Gel Sales by Application (2021-2026) & (K Units) Table 53. Global Hemostatic Gel Sales Market Share in Volume by Application (2021-2026) Table 54. Global Hemostatic Gel Sales by Application (2021-2026) & (US$ Million) Table 55. Global Hemostatic Gel Sales Market Share in Value by Application (2021-2026) Table 56. Global Hemostatic Gel Price by Application (2021-2026) & (US$/Unit) Table 57. Global Hemostatic Gel Sales by Application (2027-2032) & (K Units) Table 58. Global Hemostatic Gel Sales Market Share in Volume by Application (2027-2032) Table 59. Global Hemostatic Gel Sales by Application (2027-2032) & (US$ Million) Table 60. Global Hemostatic Gel Sales Market Share in Value by Application (2027-2032) Table 61. Global Hemostatic Gel Price by Application (2027-2032) & (US$/Unit) Table 62. North America Hemostatic Gel Sales by Application (2021-2026) & (K Units) Table 63. North America Hemostatic Gel Sales by Application (2021-2026) & (US$ Million) Table 64. Europe Hemostatic Gel Sales by Application (2021-2026) & (K Units) Table 65. Europe Hemostatic Gel Sales by Application (2021-2026) & (US$ Million) Table 66. Asia-Pacific Hemostatic Gel Sales by Application (2021-2026) & (K Units) Table 67. Asia-Pacific Hemostatic Gel Sales by Application (2021-2026) & (US$ Million) Table 68. Latin America Hemostatic Gel Sales by Application (2021-2026) & (K Units) Table 69. Latin America Hemostatic Gel Sales by Application (2021-2026) & (US$ Million) Table 70. Middle East and Africa Hemostatic Gel Sales by Application (2021-2026) & (K Units) Table 71. Middle East and Africa Hemostatic Gel Sales by Application (2021-2026) & (US$ Million) Table 72. Baxter Company Information Table 73. Baxter Business Overview Table 74. Baxter Hemostatic Gel Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 75. Baxter Hemostatic Gel Product Portfolio Table 76. Baxter Recent Development Table 77. J&J Company Information Table 78. J&J Business Overview Table 79. J&J Hemostatic Gel Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 80. J&J Hemostatic Gel Product Portfolio Table 81. J&J Recent Development Table 82. CryoLife Company Information Table 83. CryoLife Business Overview Table 84. CryoLife Hemostatic Gel Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 85. CryoLife Hemostatic Gel Product Portfolio Table 86. CryoLife Recent Development Table 87. Integra Life Sciences Company Information Table 88. Integra Life Sciences Business Overview Table 89. Integra Life Sciences Hemostatic Gel Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 90. Integra Life Sciences Hemostatic Gel Product Portfolio Table 91. Integra Life Sciences Recent Development Table 92. Advance Medical Solution Company Information Table 93. Advance Medical Solution Business Overview Table 94. Advance Medical Solution Hemostatic Gel Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 95. Advance Medical Solution Hemostatic Gel Product Portfolio Table 96. Advance Medical Solution Recent Development Table 97. BD Company Information Table 98. BD Business Overview Table 99. BD Hemostatic Gel Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 100. BD Hemostatic Gel Product Portfolio Table 101. BD Recent Development Table 102. CSL Behring Company Information Table 103. CSL Behring Business Overview Table 104. CSL Behring Hemostatic Gel Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 105. CSL Behring Hemostatic Gel Product Portfolio Table 106. CSL Behring Recent Development Table 107. Pfizer Company Information Table 108. Pfizer Business Overview Table 109. Pfizer Hemostatic Gel Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 110. Pfizer Hemostatic Gel Product Portfolio Table 111. Pfizer Recent Development Table 112. B Braun Company Information Table 113. B Braun Business Overview Table 114. B Braun Hemostatic Gel Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 115. B Braun Hemostatic Gel Product Portfolio Table 116. B Braun Recent Development Table 117. North America Hemostatic Gel Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 118. North America Hemostatic Gel Sales by Country (2021-2026) & (K Units) Table 119. North America Hemostatic Gel Sales Market Share by Country (2021-2026) Table 120. North America Hemostatic Gel Sales Forecast by Country (2027-2032) & (K Units) Table 121. North America Hemostatic Gel Sales Market Share Forecast by Country (2027-2032) Table 122. North America Hemostatic Gel Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 123. North America Hemostatic Gel Market Size by Country (2021-2026) & (US$ Million) Table 124. North America Hemostatic Gel Market Share by Country (2021-2026) Table 125. North America Hemostatic Gel Market Size Forecast by Country (2027-2032) & (US$ Million) Table 126. North America Hemostatic Gel Market Share Forecast by Country (2027-2032) Table 127. Europe Hemostatic Gel Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 128. Europe Hemostatic Gel Sales by Country (2021-2026) & (K Units) Table 129. Europe Hemostatic Gel Sales Market Share by Country (2021-2026) Table 130. Europe Hemostatic Gel Sales Forecast by Country (2027-2032) & (K Units) Table 131. Europe Hemostatic Gel Sales Market Share Forecast by Country (2027-2032) Table 132. Europe Hemostatic Gel Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 133. Europe Hemostatic Gel Market Size by Country (2021-2026) & (US$ Million) Table 134. Europe Hemostatic Gel Market Share by Country (2021-2026) Table 135. Europe Hemostatic Gel Market Size Forecast by Country (2027-2032) & (US$ Million) Table 136. Europe Hemostatic Gel Market Share Forecast by Country (2027-2032) Table 137. Asia-Pacific Hemostatic Gel Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 138. Asia-Pacific Hemostatic Gel Sales by Country (2021-2026) & (K Units) Table 139. Asia-Pacific Hemostatic Gel Sales Market Share by Country (2021-2026) Table 140. Asia-Pacific Hemostatic Gel Sales Forecast by Country (2027-2032) & (K Units) Table 141. Asia-Pacific Hemostatic Gel Sales Market Share Forecast by Country (2027-2032) Table 142. Asia-Pacific Hemostatic Gel Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 143. Asia-Pacific Hemostatic Gel Market Size by Country (2021-2026) & (US$ Million) Table 144. Asia-Pacific Hemostatic Gel Market Share by Country (2021-2026) Table 145. Asia-Pacific Hemostatic Gel Market Size Forecast by Country (2027-2032) & (US$ Million) Table 146. Asia-Pacific Hemostatic Gel Market Share Forecast by Country (2027-2032) Table 147. Latin America Hemostatic Gel Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 148. Latin America Hemostatic Gel Sales by Country (2021-2026) & (K Units) Table 149. Latin America Hemostatic Gel Sales Market Share by Country (2021-2026) Table 150. Latin America Hemostatic Gel Sales Forecast by Country (2027-2032) & (K Units) Table 151. Latin America Hemostatic Gel Sales Market Share Forecast by Country (2027-2032) Table 152. Latin America Hemostatic Gel Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 153. Latin America Hemostatic Gel Market Size by Country (2021-2026) & (US$ Million) Table 154. Latin America Hemostatic Gel Market Share by Country (2021-2026) Table 155. Latin America Hemostatic Gel Market Size Forecast by Country (2027-2032) & (US$ Million) Table 156. Latin America Hemostatic Gel Market Share Forecast by Country (2027-2032) Table 157. Middle East and Africa Hemostatic Gel Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 158. Middle East and Africa Hemostatic Gel Sales by Country (2021-2026) & (K Units) Table 159. Middle East and Africa Hemostatic Gel Sales Market Share by Country (2021-2026) Table 160. Middle East and Africa Hemostatic Gel Sales Forecast by Country (2027-2032) & (K Units) Table 161. Middle East and Africa Hemostatic Gel Sales Market Share Forecast by Country (2027-2032) Table 162. Middle East and Africa Hemostatic Gel Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 163. Middle East and Africa Hemostatic Gel Market Size by Country (2021-2026) & (US$ Million) Table 164. Middle East and Africa Hemostatic Gel Market Share by Country (2021-2026) Table 165. Middle East and Africa Hemostatic Gel Market Size Forecast by Country (2027-2032) & (US$ Million) Table 166. Middle East and Africa Hemostatic Gel Market Share Forecast by Country (2027-2032) Table 167. Key Raw Materials Table 168. Raw Materials Key Suppliers Table 169. Hemostatic Gel Distributors List Table 170. Hemostatic Gel Customers List Table 171. Research Programs/Design for This Report Table 172. Authors List of This Report Table 173. Secondary Sources Table 174. Primary Sources List of Figures Figure 1. Hemostatic Gel Image Figure 2. Global Hemostatic Gel Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Hemostatic Gel Market Size (2021-2032) & (US$ Million) Figure 4. Global Hemostatic Gel Sales (2021-2032) & (K Units) Figure 5. Fibrin Image Figure 6. Global Fibrin Sales YoY Growth (2021-2032) & (K Units) Figure 7. Gelatin Image Figure 8. Global Gelatin Sales YoY Growth (2021-2032) & (K Units) Figure 9. Other Image Figure 10. Global Other Sales YoY Growth (2021-2032) & (K Units) Figure 11. Global Hemostatic Gel Market Size Overview by Type (2021-2032) & (US$ Million) Figure 12. Global Hemostatic Gel Market Share by Type 2025 VS 2032 Figure 13. North America Hemostatic Gel Sales Market Share in Volume by Type in 2025 Figure 14. North America Hemostatic Gel Sales Market Share in Value by Type in 2025 Figure 15. Europe Hemostatic Gel Sales Market Share in Volume by Type in 2025 Figure 16. Europe Hemostatic Gel Sales Market Share in Value by Type in 2025 Figure 17. Asia-Pacific Hemostatic Gel Sales Market Share in Volume by Type in 2025 Figure 18. Asia-Pacific Hemostatic Gel Sales Market Share in Value by Type in 2025 Figure 19. Latin America Hemostatic Gel Sales Market Share in Volume by Type in 2025 Figure 20. Latin America Hemostatic Gel Sales Market Share in Value by Type in 2025 Figure 21. Middle East and Africa Hemostatic Gel Sales Market Share in Volume by Type in 2025 Figure 22. Middle East and Africa Hemostatic Gel Sales Market Share in Value by Type in 2025 Figure 23. Global Top 5 and 10 Hemostatic Gel Players Market Share by Revenue in 2025 Figure 24. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 25. Minimally Invasive Surgery Image Figure 26. Global Minimally Invasive Surgery Sales YoY Growth (2021-2032) & (K Units) Figure 27. General Surgery Image Figure 28. Global General Surgery Sales YoY Growth (2021-2032) & (K Units) Figure 29. Others Image Figure 30. Global Others Sales YoY Growth (2021-2032) & (K Units) Figure 31. Global Hemostatic Gel Market Size Overview by Application (2021-2032) & (US$ Million) Figure 32. Global Hemostatic Gel Market Share by Application 2025 VS 2032 Figure 33. North America Hemostatic Gel Sales Market Share in Volume by Application in 2025 Figure 34. North America Hemostatic Gel Sales Market Share in Value by Application in 2025 Figure 35. Europe Hemostatic Gel Sales Market Share in Volume by Application in 2025 Figure 36. Europe Hemostatic Gel Sales Market Share in Value by Application in 2025 Figure 37. Asia-Pacific Hemostatic Gel Sales Market Share in Volume by Application in 2025 Figure 38. Asia-Pacific Hemostatic Gel Sales Market Share in Value by Application in 2025 Figure 39. Latin America Hemostatic Gel Sales Market Share in Volume by Application in 2025 Figure 40. Latin America Hemostatic Gel Sales Market Share in Value by Application in 2025 Figure 41. Middle East and Africa Hemostatic Gel Sales Market Share in Volume by Application in 2025 Figure 42. Middle East and Africa Hemostatic Gel Sales Market Share in Value by Application in 2025 Figure 43. North America Hemostatic Gel Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 44. North America Hemostatic Gel Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. North America Hemostatic Gel Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. North America Hemostatic Gel Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Hemostatic Gel Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 48. Europe Hemostatic Gel Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Hemostatic Gel Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Europe Hemostatic Gel Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Hemostatic Gel Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 52. Asia-Pacific Hemostatic Gel Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Hemostatic Gel Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Asia-Pacific Hemostatic Gel Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Hemostatic Gel Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 56. Latin America Hemostatic Gel Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Hemostatic Gel Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Latin America Hemostatic Gel Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Hemostatic Gel Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 60. Middle East and Africa Hemostatic Gel Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Hemostatic Gel Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Middle East and Africa Hemostatic Gel Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Hemostatic Gel Value Chain Figure 64. Key Raw Materials Price Figure 65. Manufacturing Cost Structure Figure 66. Hemostatic Gel Production Mode & Process Figure 67. Direct Comparison with Distribution Share Figure 68. Distributors Profiles Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • Fibrin
  • Gelatin
  • Other
Applications
  • Minimally Invasive Surgery
  • General Surgery
  • Others
Companies covered
  • Baxter
  • J&J
  • CryoLife
  • Integra Life Sciences
  • Advance Medical Solution
  • BD
  • CSL Behring
  • Pfizer
  • B Braun

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Hemostatic Gel Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Hemostatic Gel Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Hemostatic Gel Market by Type
  6. 1.3.1 Fibrin
  7. 1.3.2 Gelatin
  8. 1.3.3 Other
  9. 1.4 Global Hemostatic Gel Market Size by Type
  10. 1.4.1 Global Hemostatic Gel Market Size Overview by Type (2021-2032)
  11. 1.4.2 Global Hemostatic Gel Historic Market Size Review by Type (2021-2026)
  12. 1.4.3 Global Hemostatic Gel Forecasted Market Size by Type (2027-2032)
  13. 1.5 Key Regions Market Size by Type
  14. 1.5.1 North America Hemostatic Gel Sales Breakdown by Type (2021-2026)
  15. 1.5.2 Europe Hemostatic Gel Sales Breakdown by Type (2021-2026)
  16. 1.5.3 Asia-Pacific Hemostatic Gel Sales Breakdown by Type (2021-2026)
  17. 1.5.4 South America Hemostatic Gel Sales Breakdown by Type (2021-2026)
  18. 1.5.5 Middle East and Africa Hemostatic Gel Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Hemostatic Gel Industry Trends
  2. 2.2 Hemostatic Gel Industry Drivers
  3. 2.3 Hemostatic Gel Industry Opportunities and Challenges
  4. 2.4 Hemostatic Gel Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Hemostatic Gel Revenue (2021-2026)
  2. 3.2 Global Top Players by Hemostatic Gel Sales (2021-2026)
  3. 3.3 Global Top Players by Hemostatic Gel Price (2021-2026)
  4. 3.4 Global Hemostatic Gel Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Hemostatic Gel Major Company Production Sites & Headquarters
  6. 3.6 Global Hemostatic Gel Company, Product Type & Application
  7. 3.7 Global Hemostatic Gel Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Hemostatic Gel Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Hemostatic Gel Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Hemostatic Gel Tier 1, Tier 2, and Tier 3
4 Hemostatic Gel Regional Status and Outlook
  1. 4.1 Global Hemostatic Gel Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Hemostatic Gel Historic Market Size by Region
  3. 4.2.1 Global Hemostatic Gel Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Hemostatic Gel Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Hemostatic Gel Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Hemostatic Gel Forecasted Market Size by Region
  7. 4.3.1 Global Hemostatic Gel Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Hemostatic Gel Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Hemostatic Gel Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Hemostatic Gel by Application
  1. 5.1 Hemostatic Gel Market by Application
  2. 5.1.1 Minimally Invasive Surgery
  3. 5.1.2 General Surgery
  4. 5.1.3 Others
  5. 5.2 Global Hemostatic Gel Market Size by Application
  6. 5.2.1 Global Hemostatic Gel Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Hemostatic Gel Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Hemostatic Gel Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Hemostatic Gel Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Hemostatic Gel Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Hemostatic Gel Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Hemostatic Gel Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Hemostatic Gel Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Baxter
  2. 6.1.1 Baxter Company Information
  3. 6.1.2 Baxter Business Overview
  4. 6.1.3 Baxter Hemostatic Gel Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Baxter Hemostatic Gel Product Portfolio
  6. 6.1.5 Baxter Recent Developments
  7. 6.2 J&J
  8. 6.2.1 J&J Company Information
  9. 6.2.2 J&J Business Overview
  10. 6.2.3 J&J Hemostatic Gel Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 J&J Hemostatic Gel Product Portfolio
  12. 6.2.5 J&J Recent Developments
  13. 6.3 CryoLife
  14. 6.3.1 CryoLife Company Information
  15. 6.3.2 CryoLife Business Overview
  16. 6.3.3 CryoLife Hemostatic Gel Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 CryoLife Hemostatic Gel Product Portfolio
  18. 6.3.5 CryoLife Recent Developments
  19. 6.4 Integra Life Sciences
  20. 6.4.1 Integra Life Sciences Company Information
  21. 6.4.2 Integra Life Sciences Business Overview
  22. 6.4.3 Integra Life Sciences Hemostatic Gel Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Integra Life Sciences Hemostatic Gel Product Portfolio
  24. 6.4.5 Integra Life Sciences Recent Developments
  25. 6.5 Advance Medical Solution
  26. 6.5.1 Advance Medical Solution Company Information
  27. 6.5.2 Advance Medical Solution Business Overview
  28. 6.5.3 Advance Medical Solution Hemostatic Gel Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Advance Medical Solution Hemostatic Gel Product Portfolio
  30. 6.5.5 Advance Medical Solution Recent Developments
  31. 6.6 BD
  32. 6.6.1 BD Company Information
  33. 6.6.2 BD Business Overview
  34. 6.6.3 BD Hemostatic Gel Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 BD Hemostatic Gel Product Portfolio
  36. 6.6.5 BD Recent Developments
  37. 6.7 CSL Behring
  38. 6.7.1 CSL Behring Company Information
  39. 6.7.2 CSL Behring Business Overview
  40. 6.7.3 CSL Behring Hemostatic Gel Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 CSL Behring Hemostatic Gel Product Portfolio
  42. 6.7.5 CSL Behring Recent Developments
  43. 6.8 Pfizer
  44. 6.8.1 Pfizer Company Information
  45. 6.8.2 Pfizer Business Overview
  46. 6.8.3 Pfizer Hemostatic Gel Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Pfizer Hemostatic Gel Product Portfolio
  48. 6.8.5 Pfizer Recent Developments
  49. 6.9 B Braun
  50. 6.9.1 B Braun Company Information
  51. 6.9.2 B Braun Business Overview
  52. 6.9.3 B Braun Hemostatic Gel Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 B Braun Hemostatic Gel Product Portfolio
  54. 6.9.5 B Braun Recent Developments
7 North America by Country
  1. 7.1 North America Hemostatic Gel Sales by Country
  2. 7.1.1 North America Hemostatic Gel Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Hemostatic Gel Sales by Country (2021-2026)
  4. 7.1.3 North America Hemostatic Gel Sales Forecast by Country (2027-2032)
  5. 7.2 North America Hemostatic Gel Market Size by Country
  6. 7.2.1 North America Hemostatic Gel Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Hemostatic Gel Market Size by Country (2021-2026)
  8. 7.2.3 North America Hemostatic Gel Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Hemostatic Gel Sales by Country
  2. 8.1.1 Europe Hemostatic Gel Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Hemostatic Gel Sales by Country (2021-2026)
  4. 8.1.3 Europe Hemostatic Gel Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Hemostatic Gel Market Size by Country
  6. 8.2.1 Europe Hemostatic Gel Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Hemostatic Gel Market Size by Country (2021-2026)
  8. 8.2.3 Europe Hemostatic Gel Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Hemostatic Gel Sales by Country
  2. 9.1.1 Asia-Pacific Hemostatic Gel Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Hemostatic Gel Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Hemostatic Gel Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Hemostatic Gel Market Size by Country
  6. 9.2.1 Asia-Pacific Hemostatic Gel Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Hemostatic Gel Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Hemostatic Gel Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Hemostatic Gel Sales by Country
  2. 10.1.1 South America Hemostatic Gel Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Hemostatic Gel Sales by Country (2021-2026)
  4. 10.1.3 South America Hemostatic Gel Sales Forecast by Country (2027-2032)
  5. 10.2 South America Hemostatic Gel Market Size by Country
  6. 10.2.1 South America Hemostatic Gel Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Hemostatic Gel Market Size by Country (2021-2026)
  8. 10.2.3 South America Hemostatic Gel Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Hemostatic Gel Sales by Country
  2. 11.1.1 Middle East and Africa Hemostatic Gel Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Hemostatic Gel Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Hemostatic Gel Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Hemostatic Gel Market Size by Country
  6. 11.2.1 Middle East and Africa Hemostatic Gel Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Hemostatic Gel Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Hemostatic Gel Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Hemostatic Gel Value Chain Analysis
  2. 12.1.1 Hemostatic Gel Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Hemostatic Gel Production Mode & Process
  7. 12.2 Hemostatic Gel Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Hemostatic Gel Distributors
  10. 12.2.3 Hemostatic Gel Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst